Nucleus offers the possibility to place orders for genetic testing, follow a test’s progress, and read results. Nucleus also provides the feature, Connecting Clinicians, which connects clinicians based on variants to facilitate knowledge sharing and further collaboration. The portal is free for all users. With this service, we want to provide clinicians with the ability to connect according to their own preferences and to share knowledge and phenotypes in rare cases of VUS or Likely Pathogenic variants.
Key features of Nucleus
Order and follow-up
Place the order easily by completing the requisition form and uploading clinical documents. By logging in at any point of the analysis, you can follow the progress of your order. The progress bar clearly shows the stage an order is at, which makes lists of orders clear and easy to follow. The notification bar will notify you whenever results are ready, updated, or you have a new suggested connection.
Read & share results
We will send you a notification when the results are available. Results can easily be viewed online, printed, or shared in safe and secure way with a colleague treating the same patient. The archive function allows you to archive patient cases, which makes your personal view of ordered tests more concise. You can easily access the archived cases with a click, and unarchive them if needed.
We will guide you through the whole diagnostic process. You may contact our Support team or log in to browse our offering and find information to frequently asked questions.
Connect with clinicians
Nucleus offers a unique possibility for ordering clinicians to become connected with fellow clinicians from all over the world, which share patients with identical matching variants. A connection is suggested when a variant is classified as either a VUS (Variants of uncertain significance) or Likely Pathogenic. With this service, we want to provide you with the possibility to connect according to your preferences to share knowledge and phenotypes to better serve your patients with rare inherited diseases.
We developed Nucleus to gain, share, and build life changing genetic knowledge.